Castle Biosciences CSTL
€ 26.42
1.22%
Quartalsbericht 2024-Q3
hinzugefügt 04.11.2024
Castle Biosciences Bilanz 2011-2024 | CSTL
Bilanz Jährlich Castle Biosciences
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-97.7 M | -121 M | -328 M | -410 M | -73.7 M | 20 M | 17.4 M | - | - | - | - | - | - |
Langfristige Schulden |
25 K | 90 K | 124 K | - | 19.3 M | 24.5 M | 17.6 M | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
1.14 M | 1.78 M | 1.18 M | - | 5.83 M | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 2.76 M | 19.3 M | 25.7 M | 18.9 M | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
47.7 M | 36.1 M | 24.9 M | 20.9 M | 15.3 M | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
62.1 M | 48.2 M | 50.8 M | 23.6 M | 34.6 M | 32.5 M | 24.1 M | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | 6.62 M | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-218 M | -161 M | -93.8 M | -62.5 M | -52.2 M | -57.5 M | -51.1 M | - | - | - | - | - | - |
Vermögenswerte |
453 M | 447 M | 463 M | 439 M | 120 M | 22.4 M | 9.82 M | - | - | - | - | - | - |
Zahlungsmittel |
98.8 M | 123 M | 330 M | 410 M | 98.8 M | 4.48 M | - | - | - | - | - | - | - |
Buchwert |
391 M | 399 M | 412 M | 416 M | 85.1 M | -10.1 M | -14.3 M | - | - | - | - | - | - |
Gesamtes Eigenkapital |
391 M | 399 M | 412 M | 416 M | 85.1 M | -56.6 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich Castle Biosciences
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
10 M | 10 M | 10 M | - | 13.4 M | 12.4 M | 11.1 M | 11.5 M | 11.9 M | 6.48 M | 6.71 M | 6.9 M | - | - | - | - | 12.5 M | 14.7 M | 17 M | 19.3 M | 19.3 M | 19.3 M | 19.3 M | 24.5 M | 24.5 M | 24.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
73.5 M | 63.4 M | 56 M | 62.1 M | 50.2 M | 46.6 M | 41.7 M | 48.2 M | 46.4 M | 36.7 M | 47.1 M | 50.8 M | 22 M | 19.6 M | 18.7 M | 23.6 M | 23.6 M | 23.6 M | 23.6 M | 34.6 M | 34.6 M | 34.6 M | 34.6 M | 32.5 M | 32.5 M | 32.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | 3 M | 6.18 M | 8.18 M | 6.62 M | 6.62 M | 6.62 M | 6.62 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-210 M | -212 M | -221 M | -218 M | -216 M | -209 M | -190 M | -161 M | -140 M | -120 M | -118 M | -93.8 M | -87.4 M | -75.6 M | -66.8 M | -62.5 M | -62.5 M | -62.5 M | -62.5 M | -52.2 M | -52.2 M | -52.2 M | -52.2 M | -57.5 M | -57.5 M | -57.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
515 M | 487 M | 459 M | 453 M | 436 M | 425 M | 427 M | 447 M | 458 M | 458 M | 444 M | 463 M | 434 M | 436 M | 437 M | 439 M | 439 M | 439 M | 439 M | 120 M | 120 M | 120 M | 120 M | 22.4 M | 22.4 M | 22.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
95 M | 85.6 M | 82.9 M | 98.8 M | 91.2 M | 95.9 M | 115 M | 123 M | 134 M | 273 M | 309 M | 330 M | 363 M | 368 M | 407 M | 410 M | 410 M | 410 M | 410 M | 98.8 M | 98.8 M | 98.8 M | 98.8 M | 4.48 M | 4.48 M | 4.48 M | - | 1.21 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
441 M | 424 M | 402 M | 391 M | 386 M | 379 M | 385 M | 399 M | 411 M | 422 M | 397 M | 412 M | 412 M | 416 M | 419 M | 416 M | 416 M | 416 M | 416 M | 85.1 M | 85.1 M | 85.1 M | 85.1 M | -10.1 M | -10.1 M | -10.1 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
441 M | 424 M | 402 M | 391 M | 386 M | 379 M | 385 M | 399 M | 411 M | 422 M | 397 M | 412 M | 412 M | 416 M | 419 M | 416 M | 416 M | 416 M | 416 M | 85.1 M | 85.1 M | 85.1 M | 85.1 M | -56.6 M | -56.6 M | -56.6 M | -53.9 M | -50.3 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung